Clau Blog
Funding news digest

Research Funding News for Doctoral and Early-Career Researchers

This is the edition of 26 October 2026. The announcements below are the ones compiled on that day. Read the current edition.

The following digest brings together a selection of notable announcements from European research bodies, each carrying implications for doctoral candidates and early-career researchers building their careers in and around Europe.

These summaries are written by Clau and each links to its original announcement. Clau is independent and not affiliated with the European Union or its research bodies.

Marie Skłodowska-Curie Actions · 21 October 2026

Interactive publication featuring over 100 success stories and testimonials

Marie Skłodowska-Curie Actions has published an interactive collection featuring more than 100 accounts from researchers who have participated in the programme. The publication allows readers to explore stories by country or institution, offering a concrete sense of the kinds of careers and projects the programme has supported. For doctoral and early-career researchers considering an application, the collection provides a practical window into what participation can look like in practice.

Marie Skłodowska-Curie Actions · 20 October 2026

Science without borders: the lasting legacy of Marie Skłodowska-Curie

An article in Horizon Magazine marks the 30th anniversary of Marie Skłodowska-Curie Actions, reflecting on three decades during which more than 150,000 researchers have taken part in the programme, including 25 Nobel laureates. The programme has grown from supporting around 800 researchers per year at its founding in 1996 to approximately 8,000 annually, with companies, including many small and medium-sized enterprises, making up close to half of participating organisations. For early-career researchers, this context underlines the scale and cross-sector reach of a programme that continues to shape research careers across Europe and beyond.

Marie Skłodowska-Curie Actions · 6 October 2026

Nobel Prizes in Medicine and Physics awarded to former MSCA fellow and supervisor

The 2026 Nobel Prizes in Physiology or Medicine and in Physics were awarded to researchers with direct connections to Marie Skłodowska-Curie Actions: Georg Nagel, recognised for discoveries related to optogenetics, was a former MSCA fellow, while Francis Halzen, honoured for contributions to the IceCube Neutrino Observatory, served as a supervisor on an MSCA-funded project. The awards highlight the long-term career trajectories that can follow from early participation in the programme. For doctoral and early-career researchers, the cases illustrate how MSCA funding has contributed to work that reached the highest levels of scientific recognition.

Marie Skłodowska-Curie Actions · 30 September 2026

Over €210 million boost for the Marie Skłodowska-Curie Actions to support more researchers in Europe

An additional allocation of more than 210 million euros has been announced for Marie Skłodowska-Curie Actions, responding to record demand from researchers worldwide: the 2026 MSCA Postdoctoral Fellowships call received 21,627 applications, the highest figure ever recorded for the programme and for any funding action across more than 40 years of EU research and innovation framework programmes. The top-up will increase budgets for both Postdoctoral Fellowships and Doctoral Networks, and forms part of the broader amended Horizon Europe Work Programme 2026 to 2027. With more than 1.3 billion euros foreseen for the programme in 2027, early-career researchers can expect continued and expanded opportunities under the final funding cycle of the current framework.

Marie Skłodowska-Curie Actions · 25 September 2026

Cancer research in the Marie Skłodowska-Curie Actions

Marie Skłodowska-Curie Actions has released a document outlining the programme's engagement with cancer research, set within its overall budget of 6.6 billion euros for the period 2021 to 2027. The programme funds researcher-driven projects across all fields on the basis of scientific excellence, supporting career development and mobility at every career stage. Doctoral and early-career researchers working in oncology or related biomedical fields may find this document useful for understanding how the programme's bottom-up funding model applies to health-focused research.

Each item summarises an announcement published by the named European research body and links to the original source; the summaries are written by Clau and the announcements belong to their respective sources. Clau is a free companion for doctoral candidates and early-career researchers.